• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p63和p73 TI结构域的内在聚集倾向与p53R175H相互作用相关,并提示p53家族中聚集事件的进一步重要性。

Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.

作者信息

Kehrloesser Sebastian, Osterburg Christian, Tuppi Marcel, Schäfer Birgit, Vousden Karen Heather, Dötsch Volker

机构信息

Institute of Biophysical Chemistry, Center for Biomolecular Magnetic Resonance and Cluster of Excellence Macromolecular Complexes (CEF), Goethe University Frankfurt, Frankfurt/Main, Germany.

Cancer Research UK, Beatson Institute, Glasgow G61 1BD, UK.

出版信息

Cell Death Differ. 2016 Dec;23(12):1952-1960. doi: 10.1038/cdd.2016.75. Epub 2016 Jul 22.

DOI:10.1038/cdd.2016.75
PMID:27447112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5136486/
Abstract

The high percentage of p53 missense mutations found in cancer has been attributed to mutant acquired oncogenic gain of functions. Different aspects of these tumour-promoting functions are caused by repression of the transcriptional activity of p53 family members p63 and p73. A subset of frequently occurring p53 mutations results in thermodynamic destabilisation of the DNA-binding domain (DBD) rendering this domain highly unstable. These conformational mutants (such as p53R175H) have been suggested to directly bind to p63 and p73 via a co-aggregation mechanism mediated by their DBDs. Although the DBDs of p63 and p73 are in fact not sufficient for the interaction as shown previously, we demonstrate here that the transactivation inhibitory (TI) domains within the α-isoform-specific C termini of p63 and p73 are essential for binding to p53R175H. Hence, the closed dimeric conformation of inactive TAp63α that renders the TI domain inaccessible prevents efficient interaction. We further show that binding to p53R175H correlates with an intrinsic aggregation propensity of the tetrameric α-isoforms conferred by an openly accessible TI domain again supporting interaction via a co-aggregation mechanism.

摘要

癌症中发现的高比例p53错义突变归因于突变获得的致癌功能增益。这些促进肿瘤功能的不同方面是由p53家族成员p63和p73转录活性的抑制引起的。一部分常见的p53突变会导致DNA结合结构域(DBD)的热力学不稳定,使该结构域高度不稳定。这些构象突变体(如p53R175H)已被认为通过由其DBD介导的共聚集机制直接与p63和p73结合。尽管如先前所示,p63和p73的DBD实际上不足以进行相互作用,但我们在此证明,p63和p73的α-异构体特异性C末端内的反式激活抑制(TI)结构域对于与p53R175H结合至关重要。因此,使TI结构域无法接近的无活性TAp63α的封闭二聚体构象阻止了有效相互作用。我们进一步表明,与p53R175H的结合与由开放可及的TI结构域赋予的四聚体α-异构体的内在聚集倾向相关,这再次支持通过共聚集机制进行相互作用。

相似文献

1
Intrinsic aggregation propensity of the p63 and p73 TI domains correlates with p53R175H interaction and suggests further significance of aggregation events in the p53 family.p63和p73 TI结构域的内在聚集倾向与p53R175H相互作用相关,并提示p53家族中聚集事件的进一步重要性。
Cell Death Differ. 2016 Dec;23(12):1952-1960. doi: 10.1038/cdd.2016.75. Epub 2016 Jul 22.
2
Regulation of the Activity in the p53 Family Depends on the Organization of the Transactivation Domain.p53 家族活性的调节依赖于转录激活域的结构。
Structure. 2018 Aug 7;26(8):1091-1100.e4. doi: 10.1016/j.str.2018.05.013. Epub 2018 Jun 28.
3
Functional interplay between MDM2, p63/p73 and mutant p53.MDM2、p63/p73与突变型p53之间的功能相互作用。
Oncogene. 2015 Aug 13;34(33):4300-10. doi: 10.1038/onc.2014.359. Epub 2014 Nov 24.
4
Backbone resonance assignments of the human p73 DNA binding domain.人p73 DNA结合结构域的主链共振归属
Biomol NMR Assign. 2016 Apr;10(1):49-51. doi: 10.1007/s12104-015-9635-x. Epub 2015 Aug 21.
5
Binding kinetics of mutant p53R175H with wild type p53 and p63: A Surface Plasmon Resonance and Atomic Force Spectroscopy study.突变型p53R175H与野生型p53和p63的结合动力学:表面等离子体共振和原子力光谱研究
Biophys Chem. 2017 Sep;228:55-61. doi: 10.1016/j.bpc.2017.07.002. Epub 2017 Jul 5.
6
The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.突变体 53 及其家族成员和同工型在癌症中的多种功能。
Int J Mol Sci. 2019 Dec 7;20(24):6188. doi: 10.3390/ijms20246188.
7
Structural diversity of p63 and p73 isoforms.p63 和 p73 异构体的结构多样性。
Cell Death Differ. 2022 May;29(5):921-937. doi: 10.1038/s41418-022-00975-4. Epub 2022 Mar 21.
8
The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.与它的同源物肿瘤抑制因子p53相比,p73 DNA结合结构域表现出更高的稳定性,并呈现协同DNA结合作用。
Biochemistry. 2008 Mar 11;47(10):3235-44. doi: 10.1021/bi7023207. Epub 2008 Feb 9.
9
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.肿瘤来源的p53突变形式的一个子集通过与p53核心结构域直接相互作用下调p63和p73。
Mol Cell Biol. 2001 Mar;21(5):1874-87. doi: 10.1128/MCB.21.5.1874-1887.2001.
10
The dominant-negative interplay between p53, p63 and p73: A family affair.p53、p63和p73之间的显性负性相互作用:家族事务。
Oncotarget. 2016 Oct 25;7(43):69549-69564. doi: 10.18632/oncotarget.11774.

引用本文的文献

1
p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partners.p53 异构体具有较高的聚集倾向,与伴侣蛋白相互作用,且缺乏与 p53 相互作用伙伴的结合。
Elife. 2025 Sep 10;13:RP103537. doi: 10.7554/eLife.103537.
2
Synergistic Anticancer Activity of HSP70 Inhibitor and Doxorubicin in Gain-of-Function Mutated p53 Breast Cancer Cells.热休克蛋白70(HSP70)抑制剂与阿霉素对功能获得性突变型p53乳腺癌细胞的协同抗癌活性
Biomedicines. 2025 Apr 24;13(5):1034. doi: 10.3390/biomedicines13051034.
3
Oncogenic p53 triggers amyloid aggregation of p63 and p73 liquid droplets.致癌性p53触发p63和p73液滴的淀粉样聚集。
Commun Chem. 2024 Sep 16;7(1):207. doi: 10.1038/s42004-024-01289-x.
4
p63: a crucial player in epithelial stemness regulation.p63:上皮干细胞调节中的关键因子。
Oncogene. 2023 Nov;42(46):3371-3384. doi: 10.1038/s41388-023-02859-4. Epub 2023 Oct 17.
5
Synuclein Proteins in Cancer Development and Progression.突触核蛋白在癌症发展和演进中的作用。
Biomolecules. 2023 Jun 12;13(6):980. doi: 10.3390/biom13060980.
6
The dual role of p63 in cancer.p63在癌症中的双重作用。
Front Oncol. 2023 Apr 27;13:1116061. doi: 10.3389/fonc.2023.1116061. eCollection 2023.
7
PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma.PRIMA-1抑制Y220C p53淀粉样蛋白聚集,并在肝细胞癌中与顺铂协同作用。
Front Mol Biosci. 2023 Apr 10;10:1165132. doi: 10.3389/fmolb.2023.1165132. eCollection 2023.
8
Disease-related p63 DBD mutations impair DNA binding by distinct mechanisms and varying degree.疾病相关的 p63 DBD 突变以不同的机制和不同程度损害 DNA 结合。
Cell Death Dis. 2023 Apr 18;14(4):274. doi: 10.1038/s41419-023-05796-y.
9
P63 and P73 Activation in Cancers with p53 Mutation.p53 突变型癌症中的 P63 和 P73 激活
Biomedicines. 2022 Jun 23;10(7):1490. doi: 10.3390/biomedicines10071490.
10
Designed Ankyrin Repeat Proteins as a tool box for analyzing p63.设计锚蛋白重复蛋白作为分析 p63 的工具包。
Cell Death Differ. 2022 Dec;29(12):2445-2458. doi: 10.1038/s41418-022-01030-y. Epub 2022 Jun 18.

本文引用的文献

1
Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level.p63对卵母细胞的质量控制基于分子和细胞水平上的一种弹簧加载激活机制。
Elife. 2016 Mar 14;5:e13909. doi: 10.7554/eLife.13909.
2
A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas.一种设计的p53聚集抑制剂可挽救卵巢癌中的p53肿瘤抑制功能。
Cancer Cell. 2016 Jan 11;29(1):90-103. doi: 10.1016/j.ccell.2015.12.002. Epub 2015 Dec 31.
3
Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding.聚集型p53的传播:交叉反应与共聚集对比种子效应
Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2443-8. doi: 10.1073/pnas.1500262112. Epub 2015 Feb 9.
4
Functional interplay between MDM2, p63/p73 and mutant p53.MDM2、p63/p73与突变型p53之间的功能相互作用。
Oncogene. 2015 Aug 13;34(33):4300-10. doi: 10.1038/onc.2014.359. Epub 2014 Nov 24.
5
Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling.突变型 p53 通过细胞自主 PDGF 受体 β 信号促进胰腺癌转移。
Cell. 2014 Apr 10;157(2):382-394. doi: 10.1016/j.cell.2014.01.066.
6
Functions of TAp63 and p53 in restraining the development of metastatic cancer.TAp63和p53在抑制转移性癌症发展中的作用。
Oncogene. 2014 Jun 19;33(25):3325-33. doi: 10.1038/onc.2013.287. Epub 2013 Jul 22.
7
Interaction of p53 with the CCT complex promotes protein folding and wild-type p53 activity.p53 与 CCT 复合物的相互作用促进蛋白质折叠和野生型 p53 活性。
Mol Cell. 2013 Jun 27;50(6):805-17. doi: 10.1016/j.molcel.2013.05.002. Epub 2013 Jun 6.
8
Analysis of the oligomeric state and transactivation potential of TAp73α.TAp73α 寡聚状态和反式激活潜力分析。
Cell Death Differ. 2013 Aug;20(8):1008-16. doi: 10.1038/cdd.2013.23. Epub 2013 Mar 29.
9
p53 mutations in cancer.癌症中的 p53 突变。
Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641.
10
Molecular mechanism of mutant p53 stabilization: the role of HSP70 and MDM2.突变型 p53 稳定的分子机制:热休克蛋白 70 和 MDM2 的作用。
PLoS One. 2012;7(12):e51426. doi: 10.1371/journal.pone.0051426. Epub 2012 Dec 12.